Figure 1.
Markov process of advanced NSCLC.
Figure 2.
Flow-chat of patients enrolled.
Table 1.
Unit cost of selections.
Table 2.
Patient characteristics.
Figure 3.
Progression-free survival and overall survival of patients.
Figure 4.
One-year costs (with 95%CI) of PFS without progression and PDS remaining alive.
Figure 5.
Mean monthly costs (with 95%CI) of PFS without progression.
Figure 6.
Mean monthly costs (with 95%CI) of PDS remaining alive.
Figure 7.
Mean costs (with 95%CI) in terminal phase of 1, 2 and 3 months.